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The rapid transit from hypoxia to normoxia in the lung
that follows the first breath in newborn mice coin-
cides with alveolar macrophage (AM) differentiation.
However, whether sensing of oxygen affects AM
maturation and function has not been previously
explored. We have generated mice whose AMs
show a deficient ability to sense oxygen after birth
by deleting Vhl, a negative regulator of HIF transcrip-
tion factors, in the CD11c compartment (CD11cDVhl
mice). VHL-deficient AMs show an immature-like
phenotype and an impaired self-renewal capacity
in vivo that persists upon culture ex vivo. VHL-defi-
cient phenotype is intrinsic in AMs derived from
monocyte precursors in mixed bone marrow chi-
meras. Moreover, unlike control Vhlfl/fl, AMs from
CD11cDVhl mice do not reverse pulmonary alveolar
proteinosis when transplanted into Csf2rb/ mice,
demonstrating that VHL contributes to AM-mediated
surfactant clearance. Thus, our results suggest that
optimal AM terminal differentiation, self-renewal,
and homeostatic function requires their intact oxy-
gen-sensing capacity.
INTRODUCTION
Tissue resident macrophages are essential for tissue homeosta-
sis and are in turn modulated by tissue factors. Alveolar macro-
phages (AMs) show a high capacity for self-maintenance by local
proliferation (Sieweke and Allen, 2013), with little repopulation by
blood-circulating monocytes in the steady state (Guilliams et al.,
2013; Hashimoto et al., 2013). Mature AMs regulate surfactant
levels in the lung (Baker et al., 2010; Robb et al., 1995; Stanley
et al., 1994). Factors including granulocyte-macrophage col-
ony-stimulating factor (GM-CSF) (Csf2/), GM-CSF receptor
(Csf2rb/) (Robb et al., 1995; Stanley et al., 1994), PPAR-g
(Schneider et al., 2014), and mammalian target of rapamycin1738 Cell Reports 24, 1738–1746, August 14, 2018 ª 2018 The Autho
This is an open access article under the CC BY-NC-ND license (http://(mTOR) (Sinclair et al., 2017) are required for AM development
and function.
Initial lung development occurs in a relatively hypoxic environ-
ment, beginning inmiceonembryonicday9 (E9) (Leeet al., 2001).
Fetal monocytes colonize the developing lung at approximately
E12.5 andE16.5 and only differentiate intomature AMs after birth
(Guilliams et al., 2013). Epithelial cell-derived GM-CSF is essen-
tial for the early commitment of AM precursors (Guilliams et al.,
2013; Schneider et al., 2014). However, it remains unknown
whether AM adaptation to increased oxygen concentration in
the postnatal lung influences AM maturation and function.
Wehypothesized that sensing the increased oxygen concentra-
tion just after birth may be important for postnatal AMmaturation.
Hypoxia-inducible transcription factors (HIFs) are the master reg-
ulators of the transcriptional response to low oxygen tensions,
and HIF depletion affects macrophage physiology (Imtiyaz et al.,
2010; Li et al., 2018; Peyssonnaux et al., 2005). Under normoxia,
HIF-asubunitsarehydroxylatedandbind to theVonHippel-Lindau
tumor suppressor protein (VHL), which is part of an E3 ubiquitin
ligasecomplex targetingHIF-a subunits for proteasomal degrada-
tion. Therefore, Vhl deletion induces normoxic expression of HIF
target genes (Cramer et al., 2003; Peyssonnaux et al., 2005).
Here, we deleted Vhl in the CD11c+ compartment (CD11cDVhl)
to desensitize AMs to oxygen after birth. Vhl deletion induced the
expression of HIF target genes and altered the AMmetabolic pro-
file. VHL-deficient AMsshowedan immature-like phenotype anda
decreasedself-renewalcapacity thatwerecell intrinsic,asdemon-
strated usingmixed bonemarrow (BM) chimeras. In addition, VHL
contributed to AM-mediated surfactant clearance in a model of
alveolar proteinosis. Our results therefore support the notion that
intact oxygen-sensing capacity is required for AM terminal differ-
entiation, self-renewal, and function.
RESULTS AND DISCUSSION
Downregulation of Hypoxia and Glycolysis during
Postnatal AM Maturation
To explore whether oxygen sensing by AMs could be linked to
their maturation, we analyzed a publicly available microarray
data (Schneider et al., 2014) containing the transcriptional profiler(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Downregulation of Hypoxia and
Glycolysis during Postnatal AM Maturation
(A) Enrichment plots from GSEA of postnatal day 2
(D2) compared with adult (AD) AMs using the
hallmark gene set collection from the Molecular
Signatures Database (MSigDB).
(B) mRNA expression (normalized log2, robust
multiarray average [RMA] counts) of core genes
from hypoxia and glycolysis gene sets in lung AMs
from postnatal day 2 (D2), D11, and adult mice.
Red and blue represent overexpressed and un-
derexpressed genes, respectively.
(C) Table depicting some classic HIF target genes.
Genes marked in red are present in Figure 1B.
(D) mRNA expression (as seen in Figure 1B) of HIF
target genes not included in the hallmark gene sets
indicated in Figure 1B (marked in black); color in-
tensity defined as seen in Figure 1B.
(E) Expression of HIF target genes from Figure 1C
in D2 and D11 AMs. Values represented as the
ratio of the mean expression in AMs from D2 or
D11 mice into the mean expression in AMs from
adult mice. ns, not significant; **p < 0.01 by column
statistics analysis, hypothetical value = 1.of AMs from pups at postnatal days 2 and 11 and from adult mice
that were 8–12 weeks old. Gene set enrichment analysis (GSEA)
wasperformedon the geneexpressionprofiles using the hallmark
collection of the Molecular Signatures Database (MSigDB). Re-
sults showed significant enrichment of both hypoxia and glycol-
ysis gene sets in immature AMs from 2-day-old pups compared
with mature AMs from adults (Figure 1A). In addition, the expres-
sion of core genes from these two enriched hallmark gene sets
was gradually downregulated during AM maturation (Figure 1B),
suggesting postnatal adaptation of AMs to oxygen. Core genes
from both gene sets included well-known HIF targets such as
Slc2a1,Hk2,Pdk1, andSlc2a3 (Figures1Band1C [genesmarked
in red]). Analysis of other classical HIF target genes inmost cases
revealed the same expression dynamics (Figures 1C and 1D). The
mean expression of all HIF target genes was thus significantly
higher in immature AMs (day 2) than in mature AMs from adult
mice, whereas no significant changes were found between post-
natal day 11 and adulthood (Figure 1E), correlatingwith the end ofCell RepAM terminal differentiation at approxi-
mately postnatal day 7 (Guilliams et al.,
2013). These results suggest that downre-
gulation of HIF activity in AMs upon expo-
sure to high oxygen tension after birthmay
be important for AM terminal differentia-
tion, concurring with the HIF-1-indepen-
dent role of mTOR in AM development af-
ter birth (Sinclair et al., 2017).
Lack of VHL Results in AM-
Immature Phenotype and Modified
Metabolic Profile
To investigate the biological significance
of oxygen-sensing modulation in AMs
after birth, we generated a genetic sys-tem to prevent HIF degradation in response to high postnatal
oxygen pressures by deleting Vhl in the CD11c lineage
(CD11c-Cre Vhlfl/fl mice). Compared to the LysM(Lyz2)-Cre
driver, the CD11c-Cre driver specifically targets postnatal
AMs (Guilliams et al., 2013). Vhl deletion leads to an increased
glycolytic activity of macrophages under basal conditions
(Cramer et al., 2003). Sorted bronchoalveolar lavage (BAL)
AMs from CD11c-Cre+ Vhlfl/fl (CD11cDVhl) mice showed
decreased Vhl mRNA levels relative to AMs from CD11c-
Cre Vhlfl/fl littermates (control Vhlfl/fl) (Figure 2A). Vhl deletion
in AMs resulted in the increased expression of HIF-1 targets
such as Ldha (lactate dehydrogenase) (Semenza et al.,
1996), HIF-2 targets such as Arg1 (arginase 1) (Takeda et al.,
2010), and common HIF-1 and HIF-2 target genes such as
Slc2a1 (glucose transporter 1) (Chen et al., 2001) (Figure 2B).
To explore the functional consequences of Vhl deletion in
AMs, we conducted an RNA sequencing (RNA-seq) analysis
to compare the transcriptome of BAL AMs isolated fromorts 24, 1738–1746, August 14, 2018 1739
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Figure 2. Deletion of VHL Alters AM Meta-
bolic Profile and Phenotype
(A and B) Mean expression of Vhl (A), Ldha, Arg1,
and Slc2a1 (B) by qPCR in sorted BAL AMs from
the indicated genotypes. Data represent four pools
of mice corresponding to four independent ex-
periments. n = 4–5 mice per genotype. **p < 0.01,
***p < 0.001 by ratio paired Student’s t test.
(C) Enrichment plots from GSEA analysis of
CD11cDVhl (knockout [KO]), compared with con-
trol Vhlfl/fl (wild-type [WT]) AMs using the hallmark
gene set collections as seen in Figure 1B.
(D) Oxygen-consumption rate (OCR) by BAL
AMs in the presence of glucose, glutamine,
and pyruvate sequentially treated with oligo-
mycin (Oligo), carbonyl cyanide m-chlor-
ophenylhydrazone (CCCP) and rotenone+antimy-
cin (Rot+Ant). Data are means ± SDs and are
representative of four independent experiments.
n = 6–7 mice per genotype.
(E and F) Basal respiratory rate (BRR) (E) and basal
extracellular acidification rate (ECAR) (F) of BAL
AMs. Data represent four independent experi-
ments. n = 6–7 mice per genotype. *p < 0.05 by
ratio paired Student’s t test.
(G–I) Morphological parameters of BAL AMs from
each genotype after 5-day culture in complete
medium. Representative images of H&E staining
(error bars, 50 mm) (G), mean AM size ± SEM (H),
and mean AM circularity ± SEM (I). Data are
representative of two independent experiments.
n = 4–5 mice per genotype. ***p < 0.001, by un-
paired Student’s t test.
(J) Expression of Itgax, Siglec5, Fcgr1, and Itgam
by qPCR as in (A) and (B). *p < 0.05, **p < 0.01 by
ratio paired Student’s t test.
(K) Representative flow cytometry histograms for
CD11c, Siglec-F, CD64, and CD11b (black line)
expression compared with unstained samples
(blue) in BAL AMs from the indicated genotypes.
(L) Normalized geometric mean fluorescence
intensity (GMFI) for markers from Figure 2K. Data
shown as means ± SEMs and representative
of three experiments. n = 6–7 per genotype.
***p < 0.001 by unpaired Student’s t test.
See also Figure S1.CD11cDVhl and control Vhlfl/fl mice. GSEA showed significant
enrichment of hypoxia and glycolysis gene sets from the hall-
mark collection in the absence of VHL (Figure 2C), resembling
the comparison of day 2 postnatal versus adult AMs (Figure 1A)
and indicating that, at the transcriptional level, the absence of
VHL affects the ability of AMs to detect oxygen. To address
this influence functionally, we determined the real-time meta-
bolic profile of AMs from BAL. The absence of VHL in AMs
significantly decreased their basal respiratory rate (BRR) (Fig-
ures 2D and 2E) while increasing their basal extracellular acid-1740 Cell Reports 24, 1738–1746, August 14, 2018ification rate (Figure 2F). These results
indicate that the deletion of VHL in
AMs induces the expression of HIF-1
and HIF-2 target genes and alters their
basal metabolic profile.Altered AM terminal differentiation can lead to the develop-
ment of AM-like cells with a distorted phenotype (Schneider
et al., 2014). We found that VHL-deficient AMs from BAL were
smaller and unable to acquire the fusiformmorphology of control
Vhlfl/fl AMs after culture ex vivo for 5 days, instead maintaining a
rounded shape that is similar to that of precursor cells or mono-
cytes (Figures 2G–2I) (Guilliams et al., 2013). Because altered
maturation can affect AM phenotype (Schneider et al., 2014),
we measured the expression of canonical surface markers on
BAL AMs ex vivo. VHL-deficient AMs slightly reduced mRNA
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Figure 3. Cell-Intrinsic VHL Requirement for AM Self-Renewal and Terminal Maturation
(A) In vitro BrdU assay of BAL AMs in complete RPMI (medium) or stimulated with recombinant mouse (rM)-CSF or recombinant granulocyte-macrophage
(rGM)-CSF as indicated. Data are means ± SEMs and are representative of three experiments. n = 15–18 mice of each genotype. **p < 0.01, ***p < 0.001, by
unpaired Student’s t test.
(B and C) Ki67 staining in ex vivo BAL AMs. Representative flow cytometry plots (B) and frequencies of Ki67+ cells (C). Data are means ± SEMs and are
representative of three experiments. n = 5 mice per genotype. ***p < 0.001 by unpaired Student’s t test.
(D and E) Mice were pulsed with BrdU for 3 weeks (1 mg intraperitoneally [i.p.] daily), and BrdU incorporation into BAL AMs was assessed 1 and 21 days after the
last pulse. Representative flow cytometry plots (D); frequencies of BrdU+ AMs (left) and AM turnover (right) calculated as the ratio of frequencies of BrdU+ AMs at
day 1 versus day 21 (E). Data are means ± SEMs and are representative of three experiments. n = 5 mice per genotype. ***p < 0.001; ns, not significant, by
unpaired Student’s t test.
(F) Total lung AM number. Data are means ± SEMs and show a pool of two experiments representative of four performed. n = 5–6 per genotype. ***p < 0.001; ns,
not significant, by unpaired Student’s t test.
(G) Flow cytometry plots and frequencies of DsRed+ (WT) and DsRed (Control Vhlfl/fl or CD11cDVhl) AMs (normalized to blood Ly6Chi monocyte frequency) from
CD45.2+ AM fraction of BM chimeras.
(legend continued on next page)
Cell Reports 24, 1738–1746, August 14, 2018 1741
for Itgax (CD11c) without affecting membrane receptor expres-
sion (Figures 2J–2L). Notably, VHL-deficient AMs showed
decreased mRNA and protein for Siglec5 (Siglec-F) and Fcgr1a
(CD64), whereas Itgam (CD11b) was increased (Figures 2J–2L).
This phenotype is linked to an immature AM state (Guilliams
et al., 2013; Schneider et al., 2014).
Although access to the alveolar niche is restricted in steady-
state conditions, blood monocytes can access the lung alveoli
and differentiate into AMs under specific conditions (Hashimoto
et al., 2013). Thus, the immature-like phenotype of VHL-deficient
AMs could be either cell intrinsic or caused by increased infiltra-
tion of monocytes in CD11cDVhl mice. To investigate this, we
performed surgical parabiosis of CD45.1 wild-type (WT) mice
with either CD45.2 control Vhlfl/fl or CD11cDVhl mice (Fig-
ure S1A). After 30 days, analysis of the peripheral blood in
CD45.2 parabionts revealed equivalent frequencies of CD45.1+
neutrophils and Ly6Chi monocytes, found at the same level
as those exchanged after longer protocols of parabiosis in the
steady state (Hashimoto et al., 2013) (Figures S1B and S1C).
Lung CD45.1+ Ly6Chi monocytes and BAL AMs frequencies
were similar in both genotypes (Figures S1D and S1E). These
results suggest that the immature-like phenotype of VHL-defi-
cient AMs is caused by a cell-autonomous effect and is not a
consequence of differential lung infiltration by monocytes.
Cell-Cycle Regulation and Lipid Handling Are Altered in
VHL-Deficient AMs
RNA-seq identified 2,531 differentially expressed genes in
CD11cDVhl AMs relative to control Vhlfl/fl and control CD11cCre+
AMs (Figure S2A). Functional analysis of these genes with Inge-
nuity Pathway Analysis software revealed several pathways
altered by the absence of VHL in AMs (Figure S2B). We validated
the expression of selected genes in pathways related to relevant
features of AM physiology, such as cell cycle and liver X recep-
tor/retinoid X receptor (LXR/RXR) activation, the latter being
implicated in intracellular lipid sensing (Figures S2C and S2D).
The absence of VHL in AMs resulted in the reduced expression
of genes involved in cell-cycle progression, such as cyclin B1
(Ccnb1), cyclin B2 (Ccnb2), CDK1 (Cdk1), CD25c (Cd25c), and
PLK3 (Plk3) (Figure S2C [top]) and cell-cycle control, including
BRCA1 (Brca1), CHEK1 (Chek1), and CHEK2 (Chek2), while the
cell-cycle master regulators p53 (Tp53) and p21 (Cdkn1a) dis-
played similar expression levels (Figure S2C [bottom]). Among
those genes associated with the LXR/RXR activation pathway,
upregulated transcript expression of LXRa (Nr1h3) and LXRb
(Nr1h2) genes (Figure S2D) was confirmed. In accordance with
this, we confirmed that there was an increased expression of
genes involved in cholesterol efflux, such as the transporters
ABCG1 (Abcg1) and apolipoprotein E (ApoE) and the lipoprotein
remodeling enzyme PLTP (Pltp) (Figure S2D). These results sug-(H and I) Staining of Ki67 in ex vivoBAL AMs of the indicated genotypes from BM c
AMs (I).
(J and K) Representative flow cytometry histograms for AM selected markers (red
BAL AMs from the indicated BM chimera (J). Normalized geometric mean fluore
(G, I, and K) Data shown asmeans ±SEMs and are representative of three (G) or tw
Student’s t test.
See also Figures S2 and S3.
1742 Cell Reports 24, 1738–1746, August 14, 2018gest that crucial distinctive features of AMs, such as proliferation
and lipid handling, are affected by the absence of VHL.
Functional VHL Is Required for AM Self-Renewal
Capacity
We next investigated whether the absence of VHL affected the
self-renewal capacity of AMs. Wemeasured bromodeoxyuridine
(BrdU) incorporation in BAL AMs cultured in vitro in the absence
or presence of macrophage colony-stimulating factor (M-CSF)
and GM-CSF, tissue-derived cytokines that contribute to the
maintenance and proliferation of mature AMs (Hashimoto
et al., 2013). VHL-deficient AMs proliferated significantly less
than did control Vhlfl/fl AMs both in the absence and presence
of these cytokines (Figure 3A).
To further investigate the potential role of VHL in AM self-
renewal, we analyzed BAL AMs ex vivo. These experiments re-
vealed significantly reduced Ki67 staining in VHL-deficient AMs
than in control Vhlfl/fl AMs (Figures 3B and 3C), suggesting
impaired proliferation. We next tracked self-renewal in vivo
by injecting BrdU intraperitoneally every day for 3 consecutive
weeks. One day after the last pulse, VHL-deficient AMs from
BAL showed lower BrdU incorporation than control Vhlfl/fl AMs
(Figures 3D and 3E), which is indicative of a decreased replica-
tion rate. In contrast, 21 days after the last pulse, BrdU labeling
was similar in both genotypes (Figures 3D and 3E), which trans-
lated into a lower fold dilution of the incorporated BrdU in the
absence of VHL (Figure 3F [right]). Despite the reduced turnover
in VHL-deficient AMs, total lung AMnumbers were similar in both
genotypes (Figure 3F), suggesting that VHL-deficient AMs have
a longer lifespan. Consistent with this, previous results showed
increased primary macrophage survival under hypoxia (Roiniotis
et al., 2009) and reduced apoptosis in Phd3/ BM-macro-
phages (Swain et al., 2014).
AMs are replaced by BM-derived blood monocytes in lethal
irradiation chimeras (Hashimoto et al., 2013; Yona et al., 2013).
Therefore, we next asked whether Vhl deletion could also affect
the replenishment of AMs after irradiation-induced cytoablation.
We generated chimeric mice by intravenous adoptive transfer of
BM cells from WT CD45.2+ DsRed mice (DsRed+) mixed at a 1:1
ratio with BM cells from either DsRed CD45.2+ CD11cDVhl
mice (WT:CD11cDVhl) or DsRed CD45.2+ control Vhlfl/fl
(WT:control Vhlfl/fl) into lethally irradiated CD45.1+ WT recipient
mice (Figures 3G–3K). After 47 days, the frequency of AMs
was analyzed. Most BAL and lung AMs (after BAL) were of donor
origin (CD45.2+) in both types of chimeras at this time point
(Figures S3A and S3B) (Hashimoto et al., 2013). Notably, the
frequency of CD11cDVhl AMs in the BAL (Figure 3G) and the
lung (Figure S3C) of chimeric mice was significantly lower
compared with control Vhlfl/fl AMs, recapitulating the suboptimal
reconstitution of the alveolar space by prolyl hydroxylase 3himeras. Representative flow cytometry plots (H) and frequencies of Ki67+ BAL
line for WT DsRed+ AMs or black line for Control Vhlfl/fl or CD11cDVhl AMs) in
scence intensity (GMFI) for AM selected markers (K).
o (I) performed. n = 5–10 per group. ***p < 0.001; ns, not significant, by unpaired
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Figure 4. VHL Contributes to Surfactant Handling by AMs
(A) OCR by BAL AMs in the presence of palmitoyl-CoA treated as seen in Figure 2D. Data are means ± SDs and are representative of three independent
experiments. n = 6–7 mice of each genotype.
(B and C) Basal respiratory rate (BRR) (B) and basal ECAR (C) of BAL AMs. Data represent three independent experiments. n = 6–7 mice per genotype.
*p < 0.05; ns, not significant, by ratio paired Student’s t test.
(D) Protein concentration in BAL from 3-month-old mice. Data are means ± SEMs and representative of three independent experiments. n = 5–9 mice per
genotype. ns, not significant, by unpaired Student’s t test.
(E–G) 53 104 AMs from control Vhlfl/fl or CD11cDVhl AMswere transferred intratracheally (i.t.) toCsfr2b/mice. Scheme of the experiment (E). After 1.5 months,
lung AM numbers (F) and BAL concentrations of total protein (G [left]) and SP-D (G [right]) were determined. Data represented as means ± SEMs of three pooled
independent experiments. Additional control mice (Csfr2b/ and Csfr2b+/) were added. n = 10–18 per group. *p < 0.05, **p < 0.01, ***p < 0.001; ns, not sig-
nificant, by one-way ANOVA and Bonferroni post hoc test. Only some relevant comparisons indicated.
See also Figure S2.(PHD3)-deficient AMs (Tavernier et al., 2017). This result corre-
lated with a significantly decreased proliferative capacity of
BAL CD11cDVhl AMs compared with WT AMs from co-trans-
ferred BM chimeras (Figures 3H and 3I). As a control, no differ-
ences were found in the potential of reconstitution of lung
eosinophils from the different donors (Figure S3D). Moreover,
CD11cDVhl AMs showed an immature-like phenotype
compared with WT AM counterparts (Figures 3J and 3K). Mono-
cytic AMprecursors only differentiate intomature AMs once they
reach the lung (Guilliams et al., 2013; Schneider et al., 2014; van
de Laar et al., 2016). Therefore, these results suggest that the
absence of VHL driven by the CD11c promoter during AM differ-
entiation intrinsically prevents their terminal phenotypic matura-
tion and restrains their self-renewal capacity, decreasing their
potential to reconstitute the alveolar niche in a context of compe-
tition with WT AMs. Because AM precursors come from oxygen-
rich arterial blood, this result also supports the notion that
VHL-mediated oxygen sensing is required but not sufficient for
AM terminal differentiation.
VHL Contributes to Surfactant Handling by AMs
Mice deficient for Csf2 (GM-CSF) or Csf2r or with Pparg deletion
in AMs show impaired AM maturation, resulting in low numbers
of lung immature AMs that accumulate lipids intracellularly
(Robb et al., 1995; Schneider et al., 2014; Stanley et al., 1994).
Immature AM-like cells from patients with surfactant accumula-
tion and Csf2/mice, as well as Pparg-deficient AMs, show an
induction of LXR signaling (Baker et al., 2010; Thomassen et al.,2007). These findings correlate with the LXR pathway activation
predicted by our RNA-seq analysis (Figure S2B) and with the
increased expression of LXR-target genes implicated in lipid
efflux in VHL-deficient AMs (Figure S2D).
To quantify the lipid b-oxidation capacity of AMs,wemeasured
the oxygen-consumption rate of BAL AMs in the presence of
palmytoyl-coenzyme A (CoA) as a carbon source (Figure 4A).
The basal respiration rate was significantly lower in AMs lacking
VHL, indicating a reduced lipid oxidation capacity (Figure 4B),
whereas the basal extracellular acidification rate was unaltered
(Figure 4C). Unlike other models of impaired AM function,
3-month-old CD11cDVhl mice did not show an increased accu-
mulation of total protein in BAL supernatants (Figure 4D).
To determine whether the decreased ability to oxidize lipids
of VHL-deficient AMs affected their therapeutic potential to
degrade surfactant excess in vivo, we transplanted a limited num-
ber of AMs from BALs of CD11cDVhl or control Vhlfl/fl mice into
Csf2rb/ mice, which lack mature AMs and spontaneously
develop lung proteinosis (Figures 4E–4G) (Robb et al., 1995). As
a marker of disease severity, we measured total protein and
surfactant protein D concentrations in BAL supernatants at
1.5 months after pulmonary macrophage transplantation (Fig-
ure 4E), a time point at which transferred WT AMs had removed
surfactant nearly at the levels found in healthy mice (Figure 4G)
(Happleet al., 2014;Suzuki et al., 2014).Consistentwithour earlier
results (Figure 3F), AM engraftment in the lung was similar in both
genotypes (Figure 4F). Transplanted AMs from CD11cDVhl mice
were less efficient than control Vhlfl/fl mice at reversing surfactantCell Reports 24, 1738–1746, August 14, 2018 1743
accumulation in BAL from Csf2rb/ recipient mice BAL (Fig-
ure 4G). These results indicate that VHL contributes to the ability
of AMs to oxidize lipids and to clear pulmonary surfactant in vivo.
In conclusion, we investigated whether AM adaptation to
increased oxygen concentrations in the postnatal lung is relevant
for AM function. Deletion of Vhl in AMs induced the expression of
HIF target genes and altered their metabolic profile, leading to
partial desensitization of AMs to oxygen. VHL-deficient AMs
resembled immature-like AMs in terms of morphology and
expression of maturation markers and have a limited self-
renewal potential and altered transcriptional signature. Experi-
ments of parabiosis and BM chimeras indicated that this is a
cell-autonomous phenotype. These results suggest that besides
lung tissue-specific factors, oxygen sensing is also needed for
AM terminal differentiation. Functionally, VHL-deficient AMs
showed defective therapeutic capacity to clear surfactant
excess in vivo. Our data therefore suggest that an intact oxy-
gen-sensing machinery is required for AM terminal differentia-
tion, self-renewal, and functional capacity.
EXPERIMENTAL PROCEDURES
Animals
Mice were bred at CNIC under specific pathogen-free conditions. C57BL/
6J-Crl mice (Charles River), Csf2rb/ mice (Robb et al., 1995), and Vhlfl/fl
mice (Menendez-Montes et al., 2016) mated with CD11c-Cre BAC transgenic
mice (Caton et al., 2007) were used. B6/SJL (Ptprca Pepcb/BoyJ) mice ex-
pressing the CD45.1 allele and DsRed (Actb-DsRed.T3) mice were both ac-
quired from the Jackson Laboratory. All of the animal procedures were
approved by the Animal Ethics Committee of the CNIC, the Madrid Autono-
mous University Ethics Committee, and the Community of Madrid Authority,
and were compliant with EU Directives 2010/63/EU and 2007/526/EC and
with Spanish law under Real Decreto 1201/2005.
Parabiosis
Parabiosis was performed by surgical attachment of the skin of two mice,
which promoted the formation of microvasculature at the site of inflammation.
CD11c-Cre+ Vhlfl/fl and CD11c-Cre Vhlfl/fl littermates were joined with B6/
SJL, expressing the CD45.1 congenic marker to facilitate cell tracking after
1 month of parabiosis.
BM Chimeras
B6/SJL mice expressing the CD45.1 congenic marker were lethally irradiated
(12 Gy) and were reconstituted intravenously (i.v.) with 5 3 106 cells of a 1:1
mixture of CD45.2+ WT DsRed+ BM cells and CD45.2+ CD11cDVhl BM cells,
or CD45.2+ WT DsRed+ BM cells and CD45.2+ control Vhlfl/fl BM cells. Mice
were analyzed 47 days after reconstitution.
AM Isolation
Mice were sacrificed with a lethal dose of pentobarbital (Dolethal, Vetoquinol).
Ten BALs per mouse were performed with a blunt fill needle (18G3 1.5; 1.23
40 mm, BD Safety Products), with 1 mL of PBS, 2.5 mM EDTA, and 2% fetal
bovine serum (FBS, HyClone) (flow cytometry buffer) at 37C. Samples were
kept on ice until further processing. Red blood cell lysis was performed at
room temperature (RT) for 3 min (RBC Lysis Buffer, Sigma-Aldrich). AMs
were counted with a Neubauer chamber and cultured in RPMI 1640 (GIBCO)
supplemented with 10% FBS plus 100 U/mL penicillin and 2 mM L-glutamine
(complete RPMI) at 37C and 5% CO2. Additional information can be found in
the Supplemental Experimental Procedures.
RNA Isolation
Cell lysiswasperformedwithbufferRLT (QIAGEN) containing10mm/mLb-mer-
captoethanol, and RNA was isolated with the RNeasy Plus Mini Kit (QIAGEN).
RNA concentration and integrity were determined with an Agilent 2100 Bio-
analyzer (Caliper Life Science). Samples with RNA integrity values >8 were1744 Cell Reports 24, 1738–1746, August 14, 2018further processed. cDNAwas prepared using theHighCapacity cDNAReverse
Transcription Kit (Applied Biosystems, Foster City, CA). Additional information
can be found in the Supplemental Experimental Procedures.
Metabolic Measurements
Real-time oxygen-consumption rate (OCR) and extracellular acidification rate
(ECAR) in AMs were determined with an XF-96 Extracellular Flux Analyzer
(Seahorse Bioscience). BAL AMs were pooled from 6–7 mice per genotype.
After red blood cell lysis, AMs were plated and incubated at 37C without
CO2 for 30 min before the Seahorse assay was run. Additional information
can be found in the Supplemental Experimental Procedures.
BrdU Proliferation In Vivo
Four groups of mice (two groups of each genotype) were injected daily with
1 mg BrdU (Sigma-Aldrich) for 2 weeks. One day and 21 days after the last in-
jection, two groups (one of each genotype) were sacrificed, and BAL AMswere
analyzed for BrdU incorporation (Hashimoto et al., 2013). The ratio of fre-
quencies of BrdU+ AMs at days 21 and 1 was calculated as a measurement
of BrdU dilution for 21 days.
Pulmonary Macrophage Transplantation
Csf2rb/micewerepulmonary transplantedwith53104BALAMpoolsof con-
trol Vhlfl/fl and CD11cDVhl mice. Receptor mice were anesthetized with keta-
mine (Imalgene, Merial) and xylazine (Rompun, Bayer). Then, a small incision
was made to partially expose the trachea and animals were intubated orotra-
cheallywithan i.v. catheter (22G, 0.9325mm;BD Insyte).Cellswere inoculated
with a pipette in 30mL of PBS. The viability of AMswas>90%after the last trans-
plantation. Six weeks after transplantation, BAL was performed with 1 mL of
PBS, centrifuged at 1,700 rpm for 5 min at RT, and supernatant was used to
measure total protein andsurfactantproteinD (SP-D) concentrations.Additional
information can be found in the Supplemental Experimental Procedures.
Flow Cytometry
Stainings were performed at 4C with the appropriate antibody (Ab) cocktail in
cold flow cytometry buffer. Samples were processed with a Spectral Analyzer
flow cytometer (SP6800, Sony), and data were analyzed with FlowJo software
(Tree Star). Additional information can be found in the Supplemental Experi-
mental Procedures.
Bioinformatics Analysis
GEO: GSE60249 Array Data
Array data (CEL files) (Schneider et al., 2014) were downloaded from GEO and
imported into R software with functions provided by the packages GEOquery
and oligo. RMA (affy package) was used for data processing, normalization,
and calculation of log2 transformed expression values. The array annotation
databasemogene11sttranscriptcluster.dbwas used tomap expression values
with their associated Ensembl gene IDs by selecting for each gene the tran-
script clusterwith thehighestmedian value across all of the samples.Additional
information can be found in the Supplemental Experimental Procedures.
RNA-Seq
BAL AMswere pooled from 5–7mice per genotype and further purified by pos-
itive selection with anti-CD11c-microbeads (Miltenyi Biotec), following the
manufacturer’s instructions. A total of three pools per genotype were used
for RNA-seq. Additional information can be found in the Supplemental Exper-
imental Procedures.
Statistical Analysis
Statistical comparisons were made with Prism version 7 (GraphPad Software,
La Jolla, CA). Statistical tests are detailed in the figure legends. p values: ns,
not significant; *p < 0.05; **p < 0.01; and ***p < 0.001.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO:
GSE108975.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2018.07.034.
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